Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 934 entries
Sorted by: Best Match Show Resources per page
Differential Effects of Calcium Channel Blockers On Behavioural Depression in Mice: S . K . SRIVASTAVA, C. NATH, G. P. GUPTA and K. N. DHAWAN, Deptt. of Pharmacology, P. S. Medical College Karamsad and Deptt. of Pharmacology K.G. Medical College, Lucknow, India.

Journal of psychopharmacology (Oxford, England)

[No authors listed]
PMID: 22291286
J Psychopharmacol. 1992 Jan;6(1):118. doi: 10.1177/026988119200600158.

No abstract available.

Cite
Differential Effects of Calcium Channel Blockers On Behavioural Depression in Mice: S . K . SRIVASTAVA, C. NATH, G. P. GUPTA and K. N. DHAWAN, Deptt. of Pharmacology, P. S. Medical College Karamsad and Deptt. of Pharmacology K.G. Medical College, Lucknow, India. J Psychopharmacol. 1992;6(1):118doi: 10.1177/026988119200600158.
(1992). Differential Effects of Calcium Channel Blockers On Behavioural Depression in Mice: S . K . SRIVASTAVA, C. NATH, G. P. GUPTA and K. N. DHAWAN, Deptt. of Pharmacology, P. S. Medical College Karamsad and Deptt. of Pharmacology K.G. Medical College, Lucknow, India. Journal of psychopharmacology (Oxford, England), 6(1), 118. https://doi.org/10.1177/026988119200600158
"Differential Effects of Calcium Channel Blockers On Behavioural Depression in Mice: S . K . SRIVASTAVA, C. NATH, G. P. GUPTA and K. N. DHAWAN, Deptt. of Pharmacology, P. S. Medical College Karamsad and Deptt. of Pharmacology K.G. Medical College, Lucknow, India." Journal of psychopharmacology (Oxford, England) vol. 6,1 (1992): 118. doi: https://doi.org/10.1177/026988119200600158
Differential Effects of Calcium Channel Blockers On Behavioural Depression in Mice: S . K . SRIVASTAVA, C. NATH, G. P. GUPTA and K. N. DHAWAN, Deptt. of Pharmacology, P. S. Medical College Karamsad and Deptt. of Pharmacology K.G. Medical College, Lucknow, India. J Psychopharmacol. 1992 Jan;6(1):118. doi: 10.1177/026988119200600158. PMID: 22291286.
Copy Download .nbib Format: NLM
The use of diuretics plus calcium channel blockers for hypertension may be associated with a higher risk of myocardial infarction but not stroke compared with the combination of diuretics plus beta blockers.

Evidence-based medicine

Cooper-DeHoff RM, Pepine CJ.
PMID: 20522694
Evid Based Med. 2010 Jun;15(3):92-3. doi: 10.1136/ebm1067.

No abstract available.

Cite
Cooper-DeHoff RM, Pepine CJ. The use of diuretics plus calcium channel blockers for hypertension may be associated with a higher risk of myocardial infarction but not stroke compared with the combination of diuretics plus beta blockers. Evid Based Med. 2010;15(3):92-3doi: 10.1136/ebm1067.
Cooper-DeHoff, R. M., & Pepine, C. J. (2010). The use of diuretics plus calcium channel blockers for hypertension may be associated with a higher risk of myocardial infarction but not stroke compared with the combination of diuretics plus beta blockers. Evidence-based medicine, 15(3), 92-3. https://doi.org/10.1136/ebm1067
Cooper-DeHoff, Rhonda M, and Pepine, Carl J. "The use of diuretics plus calcium channel blockers for hypertension may be associated with a higher risk of myocardial infarction but not stroke compared with the combination of diuretics plus beta blockers." Evidence-based medicine vol. 15,3 (2010): 92-3. doi: https://doi.org/10.1136/ebm1067
Cooper-DeHoff RM, Pepine CJ. The use of diuretics plus calcium channel blockers for hypertension may be associated with a higher risk of myocardial infarction but not stroke compared with the combination of diuretics plus beta blockers. Evid Based Med. 2010 Jun;15(3):92-3. doi: 10.1136/ebm1067. PMID: 20522694; PMCID: PMC2997535.
Copy Download .nbib Format: NLM
Retraction note to: Effects of calcium channel blockers on circulatory response to tracheal intubation in hypertensive patients: nicardipine versus diltiazem. Can J Anaesth 1995; 42: 785-8, DOI 10.1007/BF03011177.

Canadian journal of anaesthesia = Journal canadien d'anesthesie

Miller DR.
PMID: 23184628
Can J Anaesth. 2012 Dec;59(12):1174. doi: 10.1007/s12630-012-9836-z.

Further to the Expression of Concern posted online on March 13th, 2012, it is with considerable regret that the Canadian Journal of Anesthesia hereby retracts the above-cited article by Dr. Yoshitaka Fujii as a result of:(1) overwhelming evidence of...

Cite
Miller DR. Retraction note to: Effects of calcium channel blockers on circulatory response to tracheal intubation in hypertensive patients: nicardipine versus diltiazem. Can J Anaesth 1995; 42: 785-8, DOI 10.1007/BF03011177. Can J Anaesth. 2012;59(12):1174doi: 10.1007/s12630-012-9836-z.
Miller, D. R. (2012). Retraction note to: Effects of calcium channel blockers on circulatory response to tracheal intubation in hypertensive patients: nicardipine versus diltiazem. Can J Anaesth 1995; 42: 785-8, DOI 10.1007/BF03011177. Canadian journal of anaesthesia = Journal canadien d'anesthesie, 59(12), 1174. https://doi.org/10.1007/s12630-012-9836-z
Miller, Donald R. "Retraction note to: Effects of calcium channel blockers on circulatory response to tracheal intubation in hypertensive patients: nicardipine versus diltiazem. Can J Anaesth 1995; 42: 785-8, DOI 10.1007/BF03011177." Canadian journal of anaesthesia = Journal canadien d'anesthesie vol. 59,12 (2012): 1174. doi: https://doi.org/10.1007/s12630-012-9836-z
Miller DR. Retraction note to: Effects of calcium channel blockers on circulatory response to tracheal intubation in hypertensive patients: nicardipine versus diltiazem. Can J Anaesth 1995; 42: 785-8, DOI 10.1007/BF03011177. Can J Anaesth. 2012 Dec;59(12):1174. doi: 10.1007/s12630-012-9836-z. French. PMID: 23184628.
Copy Download .nbib Format: NLM
A Cost-Utility Analysis of Calcium Channel Blockers (Ccbs) Compared with Angiotensin II Receptor Blockers (Arbs) In Preventing Stroke And Myocardial Infarction Among Hypertension Patients In The Taiwan.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Fang CH, Lin KY, Huang YC, Liu L.
PMID: 27202782
Value Health. 2014 Nov;17(7):A761-2. doi: 10.1016/j.jval.2014.08.263. Epub 2014 Oct 26.

No abstract available.

Cite
Fang CH, Lin KY, Huang YC, et al. A Cost-Utility Analysis of Calcium Channel Blockers (Ccbs) Compared with Angiotensin II Receptor Blockers (Arbs) In Preventing Stroke And Myocardial Infarction Among Hypertension Patients In The Taiwan. Value Health. 2014;17(7):A761-2doi: 10.1016/j.jval.2014.08.263.
Fang, C. H., Lin, K. Y., Huang, Y. C., & Liu, L. (2014). A Cost-Utility Analysis of Calcium Channel Blockers (Ccbs) Compared with Angiotensin II Receptor Blockers (Arbs) In Preventing Stroke And Myocardial Infarction Among Hypertension Patients In The Taiwan. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A761-2. https://doi.org/10.1016/j.jval.2014.08.263
Fang, C H, et al. "A Cost-Utility Analysis of Calcium Channel Blockers (Ccbs) Compared with Angiotensin II Receptor Blockers (Arbs) In Preventing Stroke And Myocardial Infarction Among Hypertension Patients In The Taiwan." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A761-2. doi: https://doi.org/10.1016/j.jval.2014.08.263
Fang CH, Lin KY, Huang YC, Liu L. A Cost-Utility Analysis of Calcium Channel Blockers (Ccbs) Compared with Angiotensin II Receptor Blockers (Arbs) In Preventing Stroke And Myocardial Infarction Among Hypertension Patients In The Taiwan. Value Health. 2014 Nov;17(7):A761-2. doi: 10.1016/j.jval.2014.08.263. Epub 2014 Oct 26. PMID: 27202782.
Copy Download .nbib Format: NLM
Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis.

Ontario health technology assessment series

[No authors listed]
PMID: 23074496
Ont Health Technol Assess Ser. 2006;6(5):1-70. Epub 2006 Mar 01.

OBJECTIVE: To assess the effectiveness, and cost effectiveness of EECP in patients with severe anginal symptoms, secondary to chronic coronary disease, who are unresponsive to exhaustive pharmacotherapy and not candidates for surgical/percutaneous revascularization procedures (e.g., angioplasty, coronary bypass surgery)....

Cite
Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis. Ont Health Technol Assess Ser. 2006;6(5):1-70
(2006). Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis. Ontario health technology assessment series, 6(5), 1-70.
"Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis." Ontario health technology assessment series vol. 6,5 (2006): 1-70.
Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis. Ont Health Technol Assess Ser. 2006;6(5):1-70. Epub 2006 Mar 01. PMID: 23074496; PMCID: PMC3379533.
Copy Download .nbib Format: NLM
Muscle cramps: quinine derivatives likely to be effective but not recommended for routine use due to toxicity; vitamin B complex, naftidrofuryl and calcium channel blockers possibly effective.

Evidence-based medicine

Young G.
PMID: 20530611
Evid Based Med. 2010 Aug;15(4):114-5. doi: 10.1136/ebm1090. Epub 2010 Jun 08.

No abstract available.

Cite
Young G. Muscle cramps: quinine derivatives likely to be effective but not recommended for routine use due to toxicity; vitamin B complex, naftidrofuryl and calcium channel blockers possibly effective. Evid Based Med. 2010;15(4):114-5doi: 10.1136/ebm1090.
Young, G. (2010). Muscle cramps: quinine derivatives likely to be effective but not recommended for routine use due to toxicity; vitamin B complex, naftidrofuryl and calcium channel blockers possibly effective. Evidence-based medicine, 15(4), 114-5. https://doi.org/10.1136/ebm1090
Young, Gavin. "Muscle cramps: quinine derivatives likely to be effective but not recommended for routine use due to toxicity; vitamin B complex, naftidrofuryl and calcium channel blockers possibly effective." Evidence-based medicine vol. 15,4 (2010): 114-5. doi: https://doi.org/10.1136/ebm1090
Young G. Muscle cramps: quinine derivatives likely to be effective but not recommended for routine use due to toxicity; vitamin B complex, naftidrofuryl and calcium channel blockers possibly effective. Evid Based Med. 2010 Aug;15(4):114-5. doi: 10.1136/ebm1090. Epub 2010 Jun 08. PMID: 20530611.
Copy Download .nbib Format: NLM
Correction to Structure-Activity Relationship, Drug Metabolism and Pharmacokinetics Properties Optimization, and in Vivo Studies of New Brain Penetrant Triple T-Type Calcium Channel Blockers.

Journal of medicinal chemistry

Siegrist R, Pozzi D, Jacob G, Torrisi C, Colas K, Braibant B, Mawet J, Pfeifer T, de Kanter R, Roch C, Kessler M, Moon R, Corminboeuf O, Bezençon O.
PMID: 28234473
J Med Chem. 2017 Mar 09;60(5):2163. doi: 10.1021/acs.jmedchem.7b00219. Epub 2017 Feb 24.

No abstract available.

Cite
Siegrist R, Pozzi D, Jacob G, et al. Correction to Structure-Activity Relationship, Drug Metabolism and Pharmacokinetics Properties Optimization, and in Vivo Studies of New Brain Penetrant Triple T-Type Calcium Channel Blockers. J Med Chem. 2017;60(5):2163doi: 10.1021/acs.jmedchem.7b00219.
Siegrist, R., Pozzi, D., Jacob, G., Torrisi, C., Colas, K., Braibant, B., Mawet, J., Pfeifer, T., de Kanter, R., Roch, C., Kessler, M., Moon, R., Corminboeuf, O., & Bezençon, O. (2017). Correction to Structure-Activity Relationship, Drug Metabolism and Pharmacokinetics Properties Optimization, and in Vivo Studies of New Brain Penetrant Triple T-Type Calcium Channel Blockers. Journal of medicinal chemistry, 60(5), 2163. https://doi.org/10.1021/acs.jmedchem.7b00219
Siegrist, Romain, et al. "Correction to Structure-Activity Relationship, Drug Metabolism and Pharmacokinetics Properties Optimization, and in Vivo Studies of New Brain Penetrant Triple T-Type Calcium Channel Blockers." Journal of medicinal chemistry vol. 60,5 (2017): 2163. doi: https://doi.org/10.1021/acs.jmedchem.7b00219
Siegrist R, Pozzi D, Jacob G, Torrisi C, Colas K, Braibant B, Mawet J, Pfeifer T, de Kanter R, Roch C, Kessler M, Moon R, Corminboeuf O, Bezençon O. Correction to Structure-Activity Relationship, Drug Metabolism and Pharmacokinetics Properties Optimization, and in Vivo Studies of New Brain Penetrant Triple T-Type Calcium Channel Blockers. J Med Chem. 2017 Mar 09;60(5):2163. doi: 10.1021/acs.jmedchem.7b00219. Epub 2017 Feb 24. PMID: 28234473.
Copy Download .nbib Format: NLM
On the antiatherogenity of calcium channel blockers: studies in proliferating vascular smooth muscle cells on age sensitivity, dose dependent inhibitory effect, and time of action.

Archives of gerontology and geriatrics

Macía M, Lozano R, Villarroya M, García AG, Ruiz-Torres A.
PMID: 14764344
Arch Gerontol Geriatr. 2002 Jul-Aug;35(1):51-7. doi: 10.1016/s0167-4943(01)00215-1.

We study the effect of diltiazem on cultured vascular smooth muscle cells from humans and rats, paying special attention to its activity in relation to the concentrations applied, incubation times after addition and the capacity to act against the...

Cite
Macía M, Lozano R, Villarroya M, et al. On the antiatherogenity of calcium channel blockers: studies in proliferating vascular smooth muscle cells on age sensitivity, dose dependent inhibitory effect, and time of action. Arch Gerontol Geriatr. 2002;35(1):51-7doi: 10.1016/s0167-4943(01)00215-1.
Macía, M., Lozano, R., Villarroya, M., García, A. G., & Ruiz-Torres, A. (2002). On the antiatherogenity of calcium channel blockers: studies in proliferating vascular smooth muscle cells on age sensitivity, dose dependent inhibitory effect, and time of action. Archives of gerontology and geriatrics, 35(1), 51-7. https://doi.org/10.1016/s0167-4943(01)00215-1
Macía, Manual, et al. "On the antiatherogenity of calcium channel blockers: studies in proliferating vascular smooth muscle cells on age sensitivity, dose dependent inhibitory effect, and time of action." Archives of gerontology and geriatrics vol. 35,1 (2002): 51-7. doi: https://doi.org/10.1016/s0167-4943(01)00215-1
Macía M, Lozano R, Villarroya M, García AG, Ruiz-Torres A. On the antiatherogenity of calcium channel blockers: studies in proliferating vascular smooth muscle cells on age sensitivity, dose dependent inhibitory effect, and time of action. Arch Gerontol Geriatr. 2002 Jul-Aug;35(1):51-7. doi: 10.1016/s0167-4943(01)00215-1. PMID: 14764344.
Copy Download .nbib Format: NLM
Comparative Efficacy and Safety of BP-Lowering Pharmacotherapy in Patients Undergoing Maintenance Dialysis: A Network Meta-Analysis of Randomized, Controlled Trials.

Clinical journal of the American Society of Nephrology : CJASN

Shaman AM, Smyth B, Arnott C, Palmer SC, Mihailidou AS, Jardine MJ, Gallagher MP, Perkovic V, Jun M.
PMID: 32675281
Clin J Am Soc Nephrol. 2020 Aug 07;15(8):1129-1138. doi: 10.2215/CJN.12201019. Epub 2020 Jul 16.

BACKGROUND AND OBJECTIVES: Elevated BP is an important risk factor for cardiovascular disease, with a prevalence of over 80% in patients undergoing maintenance dialysis. We assessed the comparative BP-lowering efficacy and the safety of BP-lowering drugs in patients undergoing...

Cite
Shaman AM, Smyth B, Arnott C, et al. Comparative Efficacy and Safety of BP-Lowering Pharmacotherapy in Patients Undergoing Maintenance Dialysis: A Network Meta-Analysis of Randomized, Controlled Trials. Clin J Am Soc Nephrol. 2020;15(8):1129-1138doi: 10.2215/CJN.12201019.
Shaman, A. M., Smyth, B., Arnott, C., Palmer, S. C., Mihailidou, A. S., Jardine, M. J., Gallagher, M. P., Perkovic, V., & Jun, M. (2020). Comparative Efficacy and Safety of BP-Lowering Pharmacotherapy in Patients Undergoing Maintenance Dialysis: A Network Meta-Analysis of Randomized, Controlled Trials. Clinical journal of the American Society of Nephrology : CJASN, 15(8), 1129-1138. https://doi.org/10.2215/CJN.12201019
Shaman, Ahmed M, et al. "Comparative Efficacy and Safety of BP-Lowering Pharmacotherapy in Patients Undergoing Maintenance Dialysis: A Network Meta-Analysis of Randomized, Controlled Trials." Clinical journal of the American Society of Nephrology : CJASN vol. 15,8 (2020): 1129-1138. doi: https://doi.org/10.2215/CJN.12201019
Shaman AM, Smyth B, Arnott C, Palmer SC, Mihailidou AS, Jardine MJ, Gallagher MP, Perkovic V, Jun M. Comparative Efficacy and Safety of BP-Lowering Pharmacotherapy in Patients Undergoing Maintenance Dialysis: A Network Meta-Analysis of Randomized, Controlled Trials. Clin J Am Soc Nephrol. 2020 Aug 07;15(8):1129-1138. doi: 10.2215/CJN.12201019. Epub 2020 Jul 16. PMID: 32675281; PMCID: PMC7409758.
Copy Download .nbib Format: NLM
Repurposing drugs to fast-track therapeutic agents for the treatment of cryptococcosis.

PeerJ

Truong M, Monahan LG, Carter DA, Charles IG.
PMID: 29740519
PeerJ. 2018 May 04;6:e4761. doi: 10.7717/peerj.4761. eCollection 2018.

Many infectious diseases disproportionately affect people in the developing world. Cryptococcal meningitis is one of the most common mycoses in HIV-AIDS patients, with the highest burden of disease in sub-Saharan Africa. Current best treatment regimens still result in unacceptably...

Cite
Truong M, Monahan LG, Carter DA, et al. Repurposing drugs to fast-track therapeutic agents for the treatment of cryptococcosis. PeerJ. 2018;6:e4761doi: 10.7717/peerj.4761.
Truong, M., Monahan, L. G., Carter, D. A., & Charles, I. G. (2018). Repurposing drugs to fast-track therapeutic agents for the treatment of cryptococcosis. PeerJ, 6e4761. https://doi.org/10.7717/peerj.4761
Truong, Megan, et al. "Repurposing drugs to fast-track therapeutic agents for the treatment of cryptococcosis." PeerJ vol. 6 (2018): e4761. doi: https://doi.org/10.7717/peerj.4761
Truong M, Monahan LG, Carter DA, Charles IG. Repurposing drugs to fast-track therapeutic agents for the treatment of cryptococcosis. PeerJ. 2018 May 04;6:e4761. doi: 10.7717/peerj.4761. eCollection 2018. PMID: 29740519; PMCID: PMC5937474.
Copy Download .nbib Format: NLM
Basi-parallel anatomical scanning-magnetic resonance imaging for the diagnosis of reversible cerebral vasoconstriction syndrome of the basilar artery: a case report.

Acute medicine & surgery

Yamamoto A, Omori Y, Shindo A, Imai H, Suzuki H.
PMID: 29123909
Acute Med Surg. 2017 Jul 28;4(4):458-461. doi: 10.1002/ams2.300. eCollection 2017 Oct.

CASE: Reversible cerebral vasoconstriction syndrome (RCVS) is an increasingly recognized and important cause of thunderclap headache. Delays in diagnosis may cause deterioration of symptoms and concomitant unnecessary investigations. However, the diagnosis of RCVS in the acute stage remains difficult.A...

Cite
Yamamoto A, Omori Y, Shindo A, et al. Basi-parallel anatomical scanning-magnetic resonance imaging for the diagnosis of reversible cerebral vasoconstriction syndrome of the basilar artery: a case report. Acute Med Surg. 2017;4(4):458-461doi: 10.1002/ams2.300.
Yamamoto, A., Omori, Y., Shindo, A., Imai, H., & Suzuki, H. (2017). Basi-parallel anatomical scanning-magnetic resonance imaging for the diagnosis of reversible cerebral vasoconstriction syndrome of the basilar artery: a case report. Acute medicine & surgery, 4(4), 458-461. https://doi.org/10.1002/ams2.300
Yamamoto, Akitaka, et al. "Basi-parallel anatomical scanning-magnetic resonance imaging for the diagnosis of reversible cerebral vasoconstriction syndrome of the basilar artery: a case report." Acute medicine & surgery vol. 4,4 (2017): 458-461. doi: https://doi.org/10.1002/ams2.300
Yamamoto A, Omori Y, Shindo A, Imai H, Suzuki H. Basi-parallel anatomical scanning-magnetic resonance imaging for the diagnosis of reversible cerebral vasoconstriction syndrome of the basilar artery: a case report. Acute Med Surg. 2017 Jul 28;4(4):458-461. doi: 10.1002/ams2.300. eCollection 2017 Oct. PMID: 29123909; PMCID: PMC5649303.
Copy Download .nbib Format: NLM
The TRINITY Study: distribution of systolic blood pressure reductions.

Integrated blood pressure control

Sugimoto DH, Chrysant SG, Melino M, Lee J, Fernandez V, Heyrman R.
PMID: 23901293
Integr Blood Press Control. 2013 Jul 12;6:89-99. doi: 10.2147/IBPC.S45450. Print 2013.

BACKGROUND: Elevated systolic blood pressure is more difficult to control than elevated diastolic blood pressure. The objective of this prespecified analysis of the Triple Therapy with Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide in Hypertensive Patients Study (TRINITY) was to compare...

Cite
Sugimoto DH, Chrysant SG, Melino M, et al. The TRINITY Study: distribution of systolic blood pressure reductions. Integr Blood Press Control. 2013;6:89-99doi: 10.2147/IBPC.S45450.
Sugimoto, D. H., Chrysant, S. G., Melino, M., Lee, J., Fernandez, V., & Heyrman, R. (2013). The TRINITY Study: distribution of systolic blood pressure reductions. Integrated blood pressure control, 689-99. https://doi.org/10.2147/IBPC.S45450
Sugimoto, Danny H, et al. "The TRINITY Study: distribution of systolic blood pressure reductions." Integrated blood pressure control vol. 6 (2013): 89-99. doi: https://doi.org/10.2147/IBPC.S45450
Sugimoto DH, Chrysant SG, Melino M, Lee J, Fernandez V, Heyrman R. The TRINITY Study: distribution of systolic blood pressure reductions. Integr Blood Press Control. 2013 Jul 12;6:89-99. doi: 10.2147/IBPC.S45450. Print 2013. PMID: 23901293; PMCID: PMC3724275.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 934 entries